Form D · Other
GENERAL GENOMICS INC.
Oklahoma City, OK · CIK 0001834175
Offering snapshot reported Jan 27, 2026 · SEC filing
- Reported sold
- $2.78M Offering amount: $2.78M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 31, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 27, 2026 | Initial | $2,775,000 | No comparison | 21 | SEC filing |
| Jan 27, 2026 | Initial | $1,272,786 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity, Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-571349
CONVERTIBLE NOTES
Source: Form D, filed Jan 27, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aronjol Rosenthal | Director, Executive |
| Caleb Stuart | Director |
Issuer details
Industry: Other (See others in industry)
Address:
309 Nw 13 Th St. Suite 103
Oklahoma City, OK, 73103
Oklahoma City, OK, 73103